nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—ABCC3—bile duct—gallbladder cancer	0.109	0.121	CbGeAlD
Cisplatin—ABCC2—bile duct—gallbladder cancer	0.0873	0.0971	CbGeAlD
Cisplatin—ABCC2—bile—gallbladder cancer	0.0671	0.0746	CbGeAlD
Cisplatin—MT2A—gall bladder—gallbladder cancer	0.0514	0.0572	CbGeAlD
Cisplatin—MT1A—pancreas—gallbladder cancer	0.0284	0.0316	CbGeAlD
Cisplatin—NQO1—gall bladder—gallbladder cancer	0.026	0.0289	CbGeAlD
Cisplatin—ABCC3—gall bladder—gallbladder cancer	0.0233	0.0259	CbGeAlD
Cisplatin—GSTP1—gall bladder—gallbladder cancer	0.0232	0.0258	CbGeAlD
Cisplatin—ATP7A—epithelium—gallbladder cancer	0.023	0.0256	CbGeAlD
Cisplatin—MT1A—liver—gallbladder cancer	0.0181	0.0201	CbGeAlD
Cisplatin—SOD1—pancreas—gallbladder cancer	0.0179	0.02	CbGeAlD
Cisplatin—NQO1—Transcriptional activation by NRF2—KEAP1—gallbladder cancer	0.0179	0.178	CbGpPWpGaD
Cisplatin—CYP4A11—liver—gallbladder cancer	0.0167	0.0185	CbGeAlD
Cisplatin—ATP7B—liver—gallbladder cancer	0.0162	0.018	CbGeAlD
Cisplatin—MT2A—liver—gallbladder cancer	0.0151	0.0168	CbGeAlD
Cisplatin—SLC31A2—liver—gallbladder cancer	0.0148	0.0165	CbGeAlD
Cisplatin—GSTT1—liver—gallbladder cancer	0.0147	0.0164	CbGeAlD
Cisplatin—MT1A—lymph node—gallbladder cancer	0.0139	0.0154	CbGeAlD
Cisplatin—NQO1—epithelium—gallbladder cancer	0.0134	0.0149	CbGeAlD
Cisplatin—ATP7A—liver—gallbladder cancer	0.013	0.0145	CbGeAlD
Cisplatin—ATP7B—lymph node—gallbladder cancer	0.0124	0.0138	CbGeAlD
Cisplatin—MPO—epithelium—gallbladder cancer	0.0124	0.0137	CbGeAlD
Cisplatin—GSTP1—epithelium—gallbladder cancer	0.012	0.0133	CbGeAlD
Cisplatin—ABCC6—liver—gallbladder cancer	0.012	0.0133	CbGeAlD
Cisplatin—NQO1—pancreas—gallbladder cancer	0.012	0.0133	CbGeAlD
Cisplatin—SOD1—liver—gallbladder cancer	0.0114	0.0127	CbGeAlD
Cisplatin—SLC31A2—lymph node—gallbladder cancer	0.0114	0.0126	CbGeAlD
Cisplatin—SLC31A1—liver—gallbladder cancer	0.0111	0.0124	CbGeAlD
Cisplatin—MPO—pancreas—gallbladder cancer	0.011	0.0122	CbGeAlD
Cisplatin—XDH—liver—gallbladder cancer	0.011	0.0122	CbGeAlD
Cisplatin—GSTM1—liver—gallbladder cancer	0.0109	0.0121	CbGeAlD
Cisplatin—PTGS2—gall bladder—gallbladder cancer	0.0108	0.012	CbGeAlD
Cisplatin—GSTP1—pancreas—gallbladder cancer	0.0107	0.0119	CbGeAlD
Cisplatin—ATP7A—lymph node—gallbladder cancer	0.01	0.0111	CbGeAlD
Cisplatin—SOD1—lymph node—gallbladder cancer	0.00876	0.00974	CbGeAlD
Cisplatin—SLC31A1—lymph node—gallbladder cancer	0.00853	0.00949	CbGeAlD
Cisplatin—GSTM1—lymph node—gallbladder cancer	0.00833	0.00926	CbGeAlD
Cisplatin—ABCC5—liver—gallbladder cancer	0.00814	0.00905	CbGeAlD
Cisplatin—NQO1—liver—gallbladder cancer	0.00761	0.00847	CbGeAlD
Cisplatin—MPO—liver—gallbladder cancer	0.007	0.00778	CbGeAlD
Cisplatin—ABCC3—liver—gallbladder cancer	0.00683	0.0076	CbGeAlD
Cisplatin—GSTP1—liver—gallbladder cancer	0.0068	0.00757	CbGeAlD
Cisplatin—ABCC5—lymph node—gallbladder cancer	0.00624	0.00694	CbGeAlD
Cisplatin—NQO1—lymph node—gallbladder cancer	0.00584	0.00649	CbGeAlD
Cisplatin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—KEAP1—gallbladder cancer	0.00568	0.0564	CbGpPWpGaD
Cisplatin—PTGS2—epithelium—gallbladder cancer	0.0056	0.00623	CbGeAlD
Cisplatin—ABCC2—liver—gallbladder cancer	0.00546	0.00607	CbGeAlD
Cisplatin—MPO—lymph node—gallbladder cancer	0.00537	0.00597	CbGeAlD
Cisplatin—ABCC3—lymph node—gallbladder cancer	0.00524	0.00583	CbGeAlD
Cisplatin—GSTP1—lymph node—gallbladder cancer	0.00522	0.0058	CbGeAlD
Cisplatin—PTGS2—pancreas—gallbladder cancer	0.00499	0.00555	CbGeAlD
Cisplatin—SLC31A2—Copper homeostasis—TP53—gallbladder cancer	0.00468	0.0465	CbGpPWpGaD
Cisplatin—ABCC2—lymph node—gallbladder cancer	0.00419	0.00465	CbGeAlD
Cisplatin—BCHE—liver—gallbladder cancer	0.00412	0.00458	CbGeAlD
Cisplatin—ABCG2—liver—gallbladder cancer	0.00398	0.00443	CbGeAlD
Cisplatin—CYP2B6—liver—gallbladder cancer	0.00367	0.00408	CbGeAlD
Cisplatin—CYP2C9—liver—gallbladder cancer	0.00364	0.00404	CbGeAlD
Cisplatin—GSTM1—NRF2 pathway—KEAP1—gallbladder cancer	0.00351	0.0348	CbGpPWpGaD
Cisplatin—ABCB1—epithelium—gallbladder cancer	0.00346	0.00385	CbGeAlD
Cisplatin—PTGS2—liver—gallbladder cancer	0.00317	0.00353	CbGeAlD
Cisplatin—BCHE—lymph node—gallbladder cancer	0.00316	0.00351	CbGeAlD
Cisplatin—ABCB1—pancreas—gallbladder cancer	0.00309	0.00343	CbGeAlD
Cisplatin—ABCG2—lymph node—gallbladder cancer	0.00305	0.00339	CbGeAlD
Cisplatin—MT1A—Copper homeostasis—TP53—gallbladder cancer	0.00301	0.0299	CbGpPWpGaD
Cisplatin—GSTP1—NRF2 pathway—KEAP1—gallbladder cancer	0.00298	0.0296	CbGpPWpGaD
Cisplatin—NQO1—NRF2 pathway—KEAP1—gallbladder cancer	0.00291	0.0289	CbGpPWpGaD
Cisplatin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—ERBB3—gallbladder cancer	0.00268	0.0267	CbGpPWpGaD
Cisplatin—SOD1—Amyotrophic lateral sclerosis (ALS)—BCL2—gallbladder cancer	0.00266	0.0264	CbGpPWpGaD
Cisplatin—ABCC5—NRF2 pathway—KEAP1—gallbladder cancer	0.0025	0.0248	CbGpPWpGaD
Cisplatin—PTGS2—lymph node—gallbladder cancer	0.00243	0.00271	CbGeAlD
Cisplatin—ATP7B—Copper homeostasis—TP53—gallbladder cancer	0.00228	0.0227	CbGpPWpGaD
Cisplatin—CYP4A11—NRF2 pathway—KEAP1—gallbladder cancer	0.00217	0.0215	CbGpPWpGaD
Cisplatin—ABCB1—liver—gallbladder cancer	0.00196	0.00218	CbGeAlD
Cisplatin—ATP7A—Copper homeostasis—TP53—gallbladder cancer	0.00194	0.0193	CbGpPWpGaD
Cisplatin—SLC31A1—Copper homeostasis—TP53—gallbladder cancer	0.00186	0.0185	CbGpPWpGaD
Cisplatin—ABCC3—NRF2 pathway—KEAP1—gallbladder cancer	0.00184	0.0183	CbGpPWpGaD
Cisplatin—MT2A—Copper homeostasis—TP53—gallbladder cancer	0.00183	0.0181	CbGpPWpGaD
Cisplatin—ABCB1—lymph node—gallbladder cancer	0.00151	0.00167	CbGeAlD
Cisplatin—SOD1—Amyotrophic lateral sclerosis (ALS)—TP53—gallbladder cancer	0.0015	0.0149	CbGpPWpGaD
Cisplatin—ABCC2—NRF2 pathway—KEAP1—gallbladder cancer	0.00146	0.0145	CbGpPWpGaD
Cisplatin—GSTM1—C-MYB transcription factor network—BCL2—gallbladder cancer	0.00145	0.0144	CbGpPWpGaD
Cisplatin—MT2A—AP-1 transcription factor network—TP53—gallbladder cancer	0.00144	0.0143	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—NRAS—gallbladder cancer	0.00143	0.0142	CbGpPWpGaD
Cisplatin—PTGS2—Overview of nanoparticle effects—BCL2—gallbladder cancer	0.00131	0.013	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor Pathway—EGFR—gallbladder cancer	0.00131	0.013	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—EGFR—gallbladder cancer	0.00131	0.013	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—KRAS—gallbladder cancer	0.00123	0.0123	CbGpPWpGaD
Cisplatin—ABCC5—Fluoropyrimidine Activity—TP53—gallbladder cancer	0.00123	0.0122	CbGpPWpGaD
Cisplatin—MPO—C-MYB transcription factor network—BCL2—gallbladder cancer	0.00123	0.0122	CbGpPWpGaD
Cisplatin—SOD1—Copper homeostasis—TP53—gallbladder cancer	0.00117	0.0116	CbGpPWpGaD
Cisplatin—SOD1—AGE/RAGE pathway—EGFR—gallbladder cancer	0.00115	0.0114	CbGpPWpGaD
Cisplatin—GSTM1—C-MYB transcription factor network—NRAS—gallbladder cancer	0.00107	0.0106	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	0.00105	0.0104	CbGpPWpGaD
Cisplatin—MT2A—Immune System—KEAP1—gallbladder cancer	0.00104	0.0103	CbGpPWpGaD
Cisplatin—SOD1—Folate Metabolism—TP53—gallbladder cancer	0.000966	0.0096	CbGpPWpGaD
Cisplatin—GSTM1—C-MYB transcription factor network—KRAS—gallbladder cancer	0.00092	0.00914	CbGpPWpGaD
Cisplatin—MPO—C-MYB transcription factor network—NRAS—gallbladder cancer	0.000909	0.00903	CbGpPWpGaD
Cisplatin—ABCC3—Fluoropyrimidine Activity—TP53—gallbladder cancer	0.000907	0.00901	CbGpPWpGaD
Cisplatin—MPO—Folate Metabolism—TP53—gallbladder cancer	0.000843	0.00838	CbGpPWpGaD
Cisplatin—MPO—C-MYB transcription factor network—KRAS—gallbladder cancer	0.000782	0.00777	CbGpPWpGaD
Cisplatin—GSTM1—C-MYB transcription factor network—HRAS—gallbladder cancer	0.000782	0.00777	CbGpPWpGaD
Cisplatin—MPO—C-MYB transcription factor network—HRAS—gallbladder cancer	0.000665	0.00661	CbGpPWpGaD
Cisplatin—ABCG2—Fluoropyrimidine Activity—TP53—gallbladder cancer	0.000625	0.00621	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—NRAS—gallbladder cancer	0.000621	0.00617	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—KRAS—gallbladder cancer	0.000534	0.00531	CbGpPWpGaD
Cisplatin—ATP7A—Cellular responses to stress—TP53—gallbladder cancer	0.00053	0.00526	CbGpPWpGaD
Cisplatin—MT2A—Immune System—ERBB4—gallbladder cancer	0.000492	0.00489	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—NRAS—gallbladder cancer	0.000478	0.00475	CbGpPWpGaD
Cisplatin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—gallbladder cancer	0.000455	0.00452	CbGpPWpGaD
Cisplatin—MT2A—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	0.000454	0.00451	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—gallbladder cancer	0.000436	0.00433	CbGpPWpGaD
Cisplatin—MT2A—Immune System—ERBB3—gallbladder cancer	0.000425	0.00422	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—KRAS—gallbladder cancer	0.000411	0.00409	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—BCL2—gallbladder cancer	0.0004	0.00397	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	0.00035	0.00347	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—TP53—gallbladder cancer	0.000319	0.00317	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—NRAS—gallbladder cancer	0.000295	0.00293	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—TP53—gallbladder cancer	0.000278	0.00276	CbGpPWpGaD
Cisplatin—MT2A—Immune System—BCL2—gallbladder cancer	0.000274	0.00273	CbGpPWpGaD
Cisplatin—MT2A—Immune System—ERBB2—gallbladder cancer	0.000267	0.00265	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—KRAS—gallbladder cancer	0.000254	0.00252	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—NRAS—gallbladder cancer	0.000248	0.00246	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—HRAS—gallbladder cancer	0.000216	0.00215	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—KRAS—gallbladder cancer	0.000213	0.00212	CbGpPWpGaD
Cisplatin—ABCC5—Disease—ERBB4—gallbladder cancer	0.000213	0.00211	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.000207	0.00206	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—EGFR—gallbladder cancer	0.000205	0.00204	CbGpPWpGaD
Cisplatin—MT2A—Immune System—NRAS—gallbladder cancer	0.000203	0.00201	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.000201	0.002	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TP53—gallbladder cancer	0.000189	0.00188	CbGpPWpGaD
Cisplatin—MT2A—Immune System—EGFR—gallbladder cancer	0.000185	0.00184	CbGpPWpGaD
Cisplatin—ABCC5—Disease—ERBB3—gallbladder cancer	0.000184	0.00183	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—HRAS—gallbladder cancer	0.000181	0.0018	CbGpPWpGaD
Cisplatin—MT2A—Immune System—KRAS—gallbladder cancer	0.000175	0.00173	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TP53—gallbladder cancer	0.000172	0.00171	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.000157	0.00156	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HRAS—gallbladder cancer	0.000148	0.00147	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.000147	0.00146	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.000143	0.00142	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.00014	0.00139	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.000139	0.00139	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.000132	0.00131	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—HRAS—gallbladder cancer	0.00012	0.00119	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.000117	0.00116	CbGpPWpGaD
Cisplatin—ABCC5—Disease—ERBB2—gallbladder cancer	0.000115	0.00114	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—HRAS—gallbladder cancer	0.000107	0.00107	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	9.89e-05	0.000982	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	9.34e-05	0.000928	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NRAS—gallbladder cancer	8.77e-05	0.000871	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	8.3e-05	0.000824	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERBB4—gallbladder cancer	8.24e-05	0.000819	CbGpPWpGaD
Cisplatin—ABCC5—Disease—EGFR—gallbladder cancer	7.99e-05	0.000793	CbGpPWpGaD
Cisplatin—ABCC5—Disease—KRAS—gallbladder cancer	7.55e-05	0.00075	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERBB3—gallbladder cancer	7.13e-05	0.000708	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HRAS—gallbladder cancer	6.41e-05	0.000637	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERBB2—gallbladder cancer	4.47e-05	0.000444	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NRAS—gallbladder cancer	3.4e-05	0.000338	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EGFR—gallbladder cancer	3.1e-05	0.000308	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KRAS—gallbladder cancer	2.93e-05	0.000291	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HRAS—gallbladder cancer	2.49e-05	0.000247	CbGpPWpGaD
